Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lucia Mazzolai
Renin Inhibition by Aliskiren Prevents Atherosclerosis Progression: Comparison With Irbesartan, Atenolol, and Amlodipine
Hypertension
Internal Medicine
‹
1
2
Related publications
Direct Renin Inhibition: Focus on Aliskiren
Journal of Managed Care Pharmacy
Effects of the Direct Renin Inhibitor Aliskiren and Atenolol Alone or in Combination in Patients With Hypertension1
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal Medicine
Endocrinology
Aliskiren Improves Nitric Oxide Bioavailability and Limits Atherosclerosis
Hypertension
Internal Medicine
Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E-Deficient Mice
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Simultaneous Estimation of Aliskiren and Amlodipine in Combined Tablet Formulation by Simultaneous Equation and First Derivative Spectroscopic Methods
Organic & Medicinal Chemistry International Journal
Combined Aliskiren-Amlodipine Treatment for Hypertension in African Americans: Clinical Science and Management Issues
Therapeutic Advances in Cardiovascular Disease
Cardiovascular Medicine
Pharmacology
Cardiology
Inhibition of Ileal Na+/Bile Acid Cotransporter by S-8921 Reduces Serum Cholesterol and Prevents Atherosclerosis in Rabbits
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Inhibition of the Renin–angiotensin System Prevents Seizures in a Rat Model of Epilepsy
Clinical Science
Medicine
Evaluation of Amlodipine Inhibition and Antimicrobial Effects
International Journal of Pharmacy and Chemistry
